A Real-World Evidence Comparison of 1-Year Overall Survival and Relapse-Free Survival between Patients Treated with Abatacept in Combination with a Calcineurin Inhibitor and Methotrexate Versus Antithymocyte Globulin or Post-Transplant Cyclophosphamide Following Allogeneic Hematopoietic Cell Transplantation

Authors :: Leslie S. Kean
Linda J Burns
Tzuyung Douglas Kou
Christopher Bond
Roxanne Kapikian
Karissa Lozenski
Xiao-Ying Tang
Mei-Jie Zhang
Michael T Hemmer
Sean E Connolly
Martin Polinsky
Andres Gomez
Marcelo C Pasquini
Source :: Blood. 140:1373-1375
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Full Text Access

Tools